Lupin’s subsidiary -- Lupin Pharmaceuticals Inc is recalling 3,200 bottles of Testosterone Topical Solution in the US. United States Food and Drug Administration (USFDA) has received the repetitive complaints regarding the container indicating faulty pump. The US health regulator classified it as class III recall, which is initiated in a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
The product was distributed to seven major wholesale/drug chain distributors and one supermarket chain that may have further distributed the product throughout the US.
Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.
